LEXICON PHARMACEUTICALS, INC. Total Revenue

• LEXICON PHARMACEUTICALS, INC. showed an increase of +729.9% in Total Revenue from 2024 to 2025.
• This data is from LEXICON PHARMACEUTICALS, INC.'s annual report (Form 10-K), filed with the SEC on March 5, 2026.
• XBRL data for this metric is available from 2015 to 2025 (20 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
• Quarterly values from 10-Q filings: Q1 2016: $12.49 million | Q2 2016: $20.09 million | Q3 2016: $27.72 million | Q4 2016: $23.04 million | Q1 2017: $17.96 million | Q2 2017: $12.09 million | Q3 2017: $27.67 million | Q4 2017: $33.97 million | Q1 2018: $25.37 million | Q1 2018: $19.83 million | Q2 2018: $13.80 million | Q2 2018: $6.40 million | Q3 2018: $6.97 million | Q3 2018: $556.0 thousand | Q4 2018: $17.07 million | Q1 2019: $2.44 million | Q1 2019: $9.22 million | Q2 2019: $860.0 thousand | Q2 2019: $9.68 million | Q3 2019: $285.91 million | Q3 2019: $294.45 million | Q4 2019: $8.73 million | Q1 2020: $8.0 thousand | Q1 2020: $8.00 million | Q2 2020: $25.0 thousand | Q2 2020: $9.16 million | Q3 2020: $0.00 | Q3 2020: $6.63 million | Q1 2021: $27.0 thousand | Q1 2021: $0.00 | Q2 2021: $234.0 thousand | Q2 2021: $0.00 | Q3 2021: $23.0 thousand | Q3 2021: $0.00 | Q2 2022: $35.0 thousand | Q2 2022: $0.00 | Q3 2022: $39.0 thousand | Q3 2022: $0.00 | Q1 2023: $24.0 thousand | Q1 2023: $0.00 | Q2 2023: $291.0 thousand | Q2 2023: $317.0 thousand | Q3 2023: $162.0 thousand | Q3 2023: $148.0 thousand | Q1 2024: $1.13 million | Q1 2024: $1.09 million | Q2 2024: $1.65 million | Q2 2024: $1.62 million | Q3 2024: $1.74 million | Q3 2024: $1.75 million | Q1 2025: $1.26 million | Q1 2025: $1.26 million | Q2 2025: $28.87 million | Q3 2025: $14.18 million.
• Over the full 20 years of available data (2015 to 2025), LEXICON PHARMACEUTICALS, INC.'s Total Revenue has declined by 61.7%.
• Historical annual values: Fiscal year 2025: $49.80 million | Fiscal year 2024: $6.00 million | Fiscal year 2024: $31.08 million | Fiscal year 2023: $1.20 million | Fiscal year 2023: $1.11 million | Fiscal year 2022: $0.00 | Fiscal year 2022: $139.0 thousand | Fiscal year 2021: $298.0 thousand | Fiscal year 2021: $0.00 | Fiscal year 2020: $23.40 million | Fiscal year 2020: $24.00 million | Fiscal year 2019: $322.07 million | Fiscal year 2019: $32.33 million | Fiscal year 2018: $63.21 million | Fiscal year 2018: $26.58 million | Fiscal year 2017: $15.89 million | Fiscal year 2017: $91.69 million | Fiscal year 2016: $0.00 | Fiscal year 2016: $79.26 million | Fiscal year 2015: $130.01 million.
• Data sourced from SEC EDGAR public filings as of August 8, 2026.

Last verified: August 8, 2026